Skip to main content

September 2019

 

Clinical courses

Vacancy for Consultants in Drugs Division at Ministry of Health & Family Welfare

Directorate General of Health Services (DGHS) is attached office of the Department of Health & Family Welfare and has subordinate offices spread all over the country. The DGHS renders technical advice on all Medical and Public Health matters and is involved in the implementation of various Health Services.

Applications are invited for engagement of two consultants, purely cn contract basis, for a period of one year, as per details given below.

Job for Assistant Professor at RR College of Pharmacy

Established in 2005 by PKM Education Trust(R), to foster Para-medical education, R.R. College of Pharmacy in Bangalore provide just that right combination for the benefit of its students which keeps it at a level above the rest. The Academy has since its inception built a formidable name in the fields of Para-medical sciences. With an experienced faculty member, the institution is a door to all those who aspire for a bright future in the fields of pharmacy.

Post : Assistant Professor

Recruitment for various posts in Biological E. Limited | Hyderabad

Biological E. Limited, founded in 1953, the first private sector biological products company in India and the first pharmaceutical company in South India

Following positions and looking only for candidates from Pharma Injectables

Walk in interview for M.Pharm, B.Pharm, M.Sc in Quality Control, Quality Assurance, Production at Cipla

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Job in Quality Assurance, Tablet Manufacturing Department at UMEDICA Laboratories | Fresher M.Pharm, B.Pharm

UMEDICA Laboratories Pvt Ltd. was founded in 1982 by late Mr. Umed Doshi, a dynamic entrepreneur whose vision is being spurred further by the able leadership of his son, Mr. Manish Doshi - a true technocrat and an aggressive marketeer. UMEDICA is a manufacturer and exporter of pharmaceutical formulations. Since its inception, UMEDICA has established itself as a company delivering products meeting international quality standards. UMEDICA is a Government recognized Export House, with global business in over 51 countries, covering US, Central & South American countries, Africa, Asian & CIS countries.

Walk in interview for M.Pharm, B.Pharm in Tablet, Packaging Department at Torrent Pharma

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 7673 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

Require Clinical Data Manager at MakroCare

MakroCare Expert Strategic Development and Commercialization Global Partner for Pharmaceutical, Biotechnology and Medical Device industries. Our Experience, Programs and Processes bring a New Dimension to Development Strategy, Regulatory/Risk Planning & Management, Clinical Research, Medical/Scientific Support and Emerging Region Expansion.

Post : Clinical Data Manager

Work as Associate / Assistant Manager - Regulatory Affairs at Abbott India Limited

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post : Associate / Assistant Manager - Regulatory Affairs

Addressing opioid overdose continues to be one of the most urgent public health priorities for the U.S. government and making potentially lifesaving treatments more readily available is one of the top ways we can address this crisis. As we observe Prescription Opioid and Heroin Epidemic Awareness Week, a time when we acknowledge the devastating toll the opioid crisis has inflicted on our country, we felt it was essential to clarify important information about naloxone, an emergency opioid overdose reversal treatment. Naloxone is a critical tool for individuals, families, first responders and communities to help reduce opioid overdose deaths.

The Committee recommended granting a marketing authorisation for Xospata* (gilteritinib) for the treatment of adult patients who have relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation. AML is a rare type of cancer of the white blood cells (cells that fight infections). It affects approximately 1 in 10,000 people in the European Union. Xospata was reviewed under EMA's accelerated assessment procedure, reserved for medicines of major public health interest.